Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/21/2021 01/22/2021 01/25/2021 01/26/2021 01/27/2021 Date
160 176 184.1 172.56 169.25 Last
17149350 24544540 18489910 22419830 16232360 Volume
+3.78% +10.00% +4.60% -6.27% -1.92% Change
Financials
Sales 2020 16 497 M 2 545 M 2 545 M
Net income 2020 2 770 M 427 M 427 M
Net cash position 2020 6 940 M 1 071 M 1 071 M
P/E ratio 2020 140x
Yield 2020 0,21%
Sales 2021 21 402 M 3 302 M 3 302 M
Net income 2021 3 707 M 572 M 572 M
Net cash position 2021 7 787 M 1 201 M 1 201 M
P/E ratio 2021 106x
Yield 2021 0,27%
Capitalization 409 B 63 102 M 63 104 M
EV / Sales 2020 24,4x
EV / Sales 2021 18,7x
Nbr of Employees 25 743
Free-Float 56,5%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety testing... 
More about the company
Notations Surperformance© of WuXi AppTec Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about WUXI APPTEC CO., LTD.
01/11WUXI APPTEC : Atlantic Healthcare to attend WuXi Global Forum, January 11-13th 2..
AQ
2020WUXI APPTEC : Closes BuyBack and Cancellation of A Shares
MT
2020PRESS RELEASE : ViGeneron and WuXi Advanced Therapies enter Strategic Manufactur..
DJ
2020WuXi AppTec Invests $21 Million in Biotech Startup; Shares Slide
MT
2020Qualigen Therapeutics, STA Pharmaceutical Collaborate to Produce COVID-19 Dru..
MT
2020WUXI APPTEC : Third-Quarter Net Profit Fell on Higher Costs
DJ
2020WUXI APPTEC CO., LTD. : quaterly earnings release
2020WUXI APPTEC CO., LTD. : 3rd quarter report
CO
2020WUXI APPTEC : Next Day Disclosure Return
PU
2020WUXI APPTEC : Exercise of share options granted under the reserved grant of the ..
PU
2020WUXI APPTEC : Inside information proposed disposal of a shares by a shareholder
PU
2020SIRONA BIOCHEM : Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067
AQ
2020WUXI APPTEC : Articles of association
PU
2020WUXI APPTEC : (1) poll results of the first extraordinary general meeting of 202..
PU
2020Stymied at home, Korea's mom and pop investors charge into China tech stocks
RE
More news
News in other languages on WUXI APPTEC CO., LTD.
2020WUXI APPTEC CO., LTD. : publication des résultats trimestriels
2020WUXI APPTEC CO., LTD. : Veröffentlichung des Quartalsergebnisses
2020WUXI APPTEC CO., LTD. : publication des résultats semestriels
2020WUXI APPTEC CO., LTD. : Veröffentlichung des Halbjahresergebnisses
2020WUXI APPTEC CO., LTD. : publication des résultats annuels
More news
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Average target price 163,26 CNY
Last Close Price 169,25 CNY
Spread / Highest target 29,2%
Spread / Average Target -3,54%
Spread / Lowest Target -51,9%
EPS Revisions
Managers and Directors
NameTitle
Ge Li Chairman, President & Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Harry He Chairman-Supervisory Board
Guo Dong Tong Chief Operating Officer & Senior Vice President
Ellis Chu Chief Financial Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.36.65%63 102
GILEAD SCIENCES, INC.12.39%82 081
VERTEX PHARMACEUTICALS-4.69%58 574
REGENERON PHARMACEUTICALS6.72%54 415
BEIGENE, LTD.24.12%29 244
GENMAB A/S1.54%26 616